Stocks Seeing Increasingly Wild Swings After Earnings
Earnings beats aren’t enough to steady markets as stocks see bigger, more persistent swings. The article explains wha...
Which Dividend Etf Has The Lowest Fee
Short guide to identifying dividend ETFs with the absolute lowest fees and what to consider beyond price.
27,457 articles
What This Limited Sale Means for Sea Limited Investors
Sea Limited faced a challenging year with its shares down significantly. A top executive sold a chunk of stock, promp...
Prince Andrew Just Arrested: How He’ll Pay His Legal Fees
Rumors swirl about Prince Andrew facing arrest in a public-office misconduct probe. This report examines his estimate...
Anthropic’s Investors Could Ending Standoff Reshape Growth
Anthropic’s safety-first AI stance is colliding with government pressure, placing its investors in a pivotal role as ...
Is It Too Late to Buy Ethereum in 2026? Late Ethereum 2026?
The question on many investors' minds is clear: is it too late to buy Ethereum in 2026? This article breaks down the ...
Inside Mark Kvamme’s Second Bet: Ohio Growth Push
Veteran investor Mark Kvamme is rolling out a Temasek style OHIO Fund, a $500 million vehicle aimed at accelerating g...
Donald Trump Nancy Pelosi Bet on a Hidden AI Stock
Two of Washington’s most watched political figures disclosed stakes in Vistra, a mid-size energy player poised as AI ...
We Will Into Lost Decade Risk Reappears in Markets
A leading portfolio strategist warns that the market could enter another lost decade of real returns as valuations st...
From Maker Giant: Dell Rises on AI Bets and Backlogs
Dell Technologies pivots from PC maker to AI infrastructure leader, as it visits higher backlog levels and raises rev...
Microsoft 2026: Still the Smartest AI Play in Markets
As AI accelerates, Microsoft reports robust AI-driven revenue while stock faces capex-related volatility. This piece ...
Stripe Cofounder Says Will Two Majors Help Gen Z Compete
As AI reshapes the job market, a leading tech founder argues Gen Z should pursue two college majors to stay competiti...
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status